Recipharm Advanced Bio (formerly ReciBioPharm) is a global CDMO devoted to developing and manufacturing advanced therapies. The company specializes in xRNA therapies, viruses and viral vectors, microbial and live biotherapeutic products, and recombinant protein vaccines. With operations in the U.S., Germany, and Portugal, Recipharm Advanced Bio curates technologies, capabilities, and capacity to offer end-to-end solutions that streamline development programs and supports the work of xRNA therapy innovators by leveraging its integrated plasmid DNA, xRNA, and lipid nanoparticle (LNP) formulation capabilities.
